Market Tracker

10/24 6:05pm ET

Pharmacyclics Inc (NASDAQ:PCYC)

123.68
Data as of Oct 24
 +2.36 / +1.95%
Today’s Change
82.51
Today|||52-Week Range
154.89
+16.92%
Year-to-Date

Today’s Trading

Previous close121.32
Today’s open121.55
Day’s range120.53 - 124.19
Volume715,590
Average volume (3 months)896,373
Market cap$9.3B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+411.76%
Earnings growth (this year)-48.14%
Earnings growth (next 5 years)+64.50%
Revenue growth (last year)+217.32%
P/E ratio110.4
Price/Sales29.59
Price/Book14.62

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+0.12+0.22%
SLXPSalix Pharmaceutical...+4.86+3.59%
HSPHospira Inc+0.80+1.55%
RDYDr.Reddy's Laborator...+0.58+1.15%
Data as of 4:07pm ET, 10/24/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)$0.37
Annual revenue (last year)$260.2M
Annual profit (last year)$67.0M
Net profit margin25.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert W. Duggan
Chief Operating Officer
Mahkam Zanganeh
Corporate headquarters
Sunnyvale, California

Forecasts